All Stories

  1. Chitosan nanoparticles loaded by gentamicin
  2. Synthesis, characterisation and potential biomedical applications of magnetic core–shell structures: carbon-, dextran-, SiO2- and ZnO-coated Fe3O4 nanoparticles
  3. Enhanced antibacterial effect of azlocillin in conjugation with silver nanoparticles against Pseudomonas aeruginosa
  4. Bombesin conjugated gold nanoparticles: a new targeting contrast agent for imaging of breast cancer in radiology
  5. Gentamicin-gold nanoparticles conjugate: a contrast agent for X-ray imaging of infectious foci due to Staphylococcus aureus
  6. Breast cancer photothermal therapy based on gold nanorods targeted by covalently-coupled bombesin peptide
  7. Effect of annealing temperature on magnetic phase transition in Fe3O4 nanoparticles
  8. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI
  9. Anti protein A antibody-gold nanorods conjugate: a targeting agent for selective killing of methicillin resistant Staphylococcus aureus using photothermal therapy method
  10. Dependence of structural phase transition and lattice strain of Fe3O4 nanoparticles on calcination temperature
  11. Extracellular Bioynthesis of Silver Nanoparticles by Penicillium chrysogenum and Penicillium expansum
  12. Targeting Molecular Imaging Approach for Detection of Infection and Inflammation by Diagnostic Nuclear Medicine Techniques
  13. Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
  14. Enhanced delivery of gentamicin to infection foci due toStaphylococcus aureususing gold nanorods
  15. Bactericidal Effect of Silver Nanoparticles on Intramacrophage Brucella abortus 544
  16. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer
  17. Nanoemulsions and nonwoven fabrics carrying AgNPs: Antibacterial but may be cytotoxic
  18. Optimization of Keratinase Production for Feather Degradation by Bacillus subtilis
  19. Extracellular Deposition of Silver Nanoparticles byBacillus Megaterium
  20. Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer
  21. 99mTc-ceftriaxone, as a targeting radiopharmaceutical for scintigraphic imaging of infectious foci due to Staphylococcus aureus in mouse model
  22. Infectious Foci Imaging with Targeting Radiopharmaceuticals in Nuclear Medicine
  23. Development of gentamicin-gold nanospheres for antimicrobial drug delivery toStaphylococcalinfected foci
  24. Targeting Molecular Imaging of Breast Cancer by Radioimmunodetection Method in Nuclear Medicine
  25. Biosynthesis of Gold Nanoparticles by Streptomyces sp. ERI-3 Supernatant and Process Optimization for Enhanced Production
  26. Intracellular Biosynthesis of Gold Nanoparticles by FungusPhoma macrostoma
  27. Breast Cancer: Radioimmunoscintigraphy and Radioimmunotherapy
  28. Extracellular biosynthesis of silver nanoparticles using cell filtrate of Streptomyces sp. ERI-3
  29. Biological Synthesis of Gold Nanoparticles by Fungus Epicoccum nigrum
  30. Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer
  31. Comparison of 99mTc-labeled PR81 and its F(ab′)2 fragments as radioimmunoscintigraphy agents for breast cancer imaging
  32. Natural radioactivity levels of 226RA and 40K in soil of Zanjan province, Iran
  33. Erratum: Production and biological evaluation of [201Tl(III)]bleomycin
  34. Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer
  35. Evaluation of Breast Tumor Targeting with Radiolabeled F(ab’)2 Fragmant of a New Anti-MUC1 Monoclonal Antibody (PR81)
  36. Assessment of annual effective dose due to natural gamma radiation in Zanjan (Iran)
  37. Breast tumor targeting with 99mTc-HYNIC-PR81 complex as a new biologic radiopharmaceutical
  38. Production and biological evaluation of [201TI(III)]bleomycin
  39. [201Tl](III)-bleomycin for tumor imaging
  40. Breast Tumor Targeting in a Mouse Model with a New Anti-MUC1 Monoclonal Antibody, PR81, Radiolabeled with 99mTc via the HYNIC